Working... Menu

Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma (MeCAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02652910
Recruitment Status : Recruiting
First Posted : January 12, 2016
Last Update Posted : February 27, 2019
Xuzhou Medical University
Hrain Biotechnology Co., Ltd.
Shanghai Changzheng Hospital
Information provided by (Responsible Party):
Qingzhu Jia, M.D., Xinqiao Hospital of Chongqing

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : December 2019